Abstract
Background In November 2001, a 24-year-old woman with thrombocytopenia and Raynaud's phenomenon presented to our clinic. Her physical examination was unremarkable except for bruising on her legs and arms.
Investigations Laboratory assays detected the presence of antinuclear and anti-ribonucleoprotein antibodies. Tests for antibodies to double-stranded DNA and for antiphospholipid (lupus anticoagulant and anticardiolipin), anticentromere, anti-Scl-70, and antiplatelet antibodies were negative, as was a Coombs test. An echocardiogram, chest X-ray, and abdominal scan showed no abnormalities. Nailfold digital capillaroscopy revealed minor capillary changes not specific for scleroderma.
Diagnosis Undifferentiated connective tissue disease.
Management The patient was successfully treated initially with high doses of corticosteroids and azathioprine, followed by rapid dose tapering. Therapy was continued for 2 years and then stopped. Over the next 4 years the patient's disease history was unremarkable, apart from mild Raynaud's phenomenon of the hands and the presence antinuclear and anti-ribonucleoprotein antibodies. The diagnosis of undifferentiated connective tissue disease was confirmed at her most-recent assessment, in October 2007.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
LeRoy EC et al. (1980) Undifferentiated connective tissue syndromes. Arthritis Rheum 23: 341–343
Ganczarczyk L et al. (1989) Latent lupus. J Rheumatol 16: 475–478
Greer JM and Panush RS (1989) Incomplete lupus erythematosus. Arch Intern Med 149: 2473–2476
Alarcón GS et al. (1991) Early undifferentiated connective tissue disease. I. Early clinical manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well-established connective tissue disease. J Rheumatol 18: 1332–1339
Mosca M et al. (1998) Undifferentiated connective tissue diseases: the clinical and serological profiles in 91 patients followed for at least 1 year. Lupus 7: 95–100
Danieli MG et al. (1999) Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. Clin Exp Rheumatol 17: 585–591
Williams HJ et al. (1999) Early undifferentiated tissue disease. VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Rheumatol 26: 816–825
Vila LM et al. (2000) Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus 9: 110–115
Mosca M et al. (1999) Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 17: 615–620
Swaak AJ et al. (2001) Incomplete lupus erythematosus: results of a multicenter study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology 40: 89–94
Bodolay E et al. (2003) Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 21: 313–320
Mosca M et al. (2002) Undifferentiated connective tissue disease: analysis of 83 patients with a minimum follow-up of 5 years. J Rheumatol 29: 2345–2349
Mosca M et al. (2007) Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol 21: 1011–1123
Mosca M et al. (2007) Anti-C1q antibodies in pregnant patients with systemic lupus erythematosus. Clin Exp Rheumatol 25: 449–452
Rand Mariq H and Valter I (2004) A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 22 (Suppl 33): S5–S13
Asherson RA (2006) New subsets of the antiphospholipid syndrome in 2006: “PRE-APS” (probable APS) and microangiopathic antiphospholipid syndromes (“MAPS”). Autoimmun Rev 6: 76–80
Lazaro MA et al. (1989) Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity. Medicine 68: 58–65
Aringer M et al. (2005) Does mixed connective tissue disease exist? Yes. Rheum Dis Clin North Am 31: 411–420
Burdt MA et al. (1999) Long term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 42: 899–909
Doria A et al. (2005) Defining unclassifiable connective tissue diseases: incomplete, undifferentiated or both. J Rheumatol 32: 213–215
Mosca M et al. (2002) Pregnancy outcome in patients with undifferentiated connective tissue disease: a preliminary study on 25 pregnancies. Lupus 11: 304–307
Acknowledgements
Désirée Lie, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the Medscape-accredited continuing medical education activity associated with this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Mosca, M., Tani, C. & Bombardieri, S. A case of undifferentiated connective tissue disease: is it a distinct clinical entity?. Nat Rev Rheumatol 4, 328–332 (2008). https://doi.org/10.1038/ncprheum0799
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0799